REFERENCES
- Bergamaschi G, Di Sabatino A, Albertini R, et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica. 2010;95:199–205.
- Lee TW, Kolber MR, Fedorak RN, et al. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis. 2012;6:267–275.
- Carrier J, Aghdassi E, Platt I, et al. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther. 2001;15:1989–1999.
- Erichsen K, Milde AM, Arslan G, et al. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflamm Bowel Dis 2005;11:744–748.
- Barollo M, R D'I nc, Scarpa M, Medici V, et al. Effects of iron supplementation on trace elements level in a model of colitis isn rats. World J Gastroenterol 2005;11: 4396–4399.
- Oldenburg B, Van Berge Henegouwen GP, Rennick D, et al. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest 2000;30:505–510.
- Knutson MD, Walter PB, Ames B, et al. Both iron deficiency and daily iron supplementation increase lipid peroxidation in rats. J Nutr 2000;130:621–628.
- Reifen R, Nissenkorn A, Matas Z, et al. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J Gastroenterol 2004;39: 514–519.
- Minaiyan M, Mostaghel E, Mahzouni P. Preventive therapy of experimental colitis with selected iron chelators and anti-oxidants. Int J Prev Med. 2012;3(Suppl 1): S162–S169.
- Bousvaros A, Zurakowski D, Duggan C, et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediat Gastroenterol Nutr 1998;26:129–135.
- Buffington GD, Doe WF. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Rad Biol Med 1995;9:911–918.
- Erichsen K, Hausken T, Ulvik RJ, et al. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol. 2003;38:543–548.
- Erichsen K, Ulvik RJ, Nysaeter G, et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol. 2005;40:1058–1065.
- Silver BJ, Hamilton BD, Toossi Z. Suppression of TNF-alpha gene expression by hemin: implications for the role of iron homeostasis in host inflammatory 0responses. J Leukoc Biol. 1997;62:547–552.
- Schubert TE, Bosserhoff AK, Peyssonaux C, et al. Hypoferraemia during the early inflammatory response is dependent on tumour necrosis factor activity in a murine model of protracted peritonitis. Mol Med Rep. 2012;6: 838–842.
- Ghio AJ, Weinberg ED. Complications of TNF-α antagonists and iron homeostasis. Med Hypotheses. 2012;78:33–35.
- Triantafillidis JK, Papalois A, Parassi A, et al. Favourable response to subcutaneous administration of Infliximab in experimental colitis in rats. World J Gastroenterol 2005;11:6843–6847.
- Triantafillidis JK, Douvi G, Agrogiannis G, et al. Effect of mesalamine and prednisolone on TNBS experimental colitis, following various doses of orally administered iron. Bio Med Res Int 2014;2014:8.
- Geboes K, Riddell R, Öst A, et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000;47:404–409.
- Carrier J, Aghdassi E, Cullen J, et al. Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. J Nutr 2002;132:3146–3150.
- Neurath MF, Fuss I, Pasparakis M, et al. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 1997;27:1743– 1750.
- Fuss IJ, Marth T, Neurath MF, et al. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology 1999;117:1078– 1088.
- Millar AD, Rampton DS, Blake DR. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment Pharmacol Ther 2000;14: 1163–1168.
- Tsay J, Yang Z, Ross FP, et al. Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood. 2010;116: 2582–2589.
- Polla BS. Therapy by taking away: the case of iron. Biochem Pharmacol 1999;57:1345–1349.
- Ghio AJ, Weinberg ED. Complications of TNF-α antagonists and iron homeostasis. Med Hypotheses. 2012;78:33–35.